Finance

Lists
VRPX:OTCMKTS
Virpax Pharmaceuticals Inc
0,16 $
0,00%
(0,00) 1D
28 қыр., 12:12:48 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VRPX...
Mkt. cap
198,17 м.
Avg. vol.
306,00
Volume
11,00
52-wk high
0,21 $
52-wk low
0,00 $
Beta
1,14
Shares outstanding
1,24 млн
No. of employees
2
Mkt. cap
198,17 м.
Avg. vol.
306,00
Volume
11,00
52-wk high
0,21 $
52-wk low
0,00 $
Beta
1,14
Shares outstanding
1,24 млн
No. of employees
2
News stories
From web sources and news partners
About Virpax Pharmaceuticals Inc
CEO-
Employees2
Founded2016
HeadquartersBerwyn, Пенсильвания, Америка Құрама Штаттары
SectorPharmaceutical industry
Websitevirpaxpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2023 ж. жел.
2024 ж. мау.
2024 ж. қыр.
2024 ж. жел.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
1,14 млн
1,11 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
780,96 м.
2,29 млн
Operating expense
-
-
1,92 млн
3,39 млн
Total operating expenses
-
-
1,92 млн
3,39 млн
Operating income
-
-
-1,92 млн
-3,39 млн
Other non operating income
-
-
10,65 мың
4,65 мың
EBT including unusual items
-
-
-2,01 млн
-3,39 млн
EBT excluding unusual items
-
-
-2,01 млн
-3,39 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-2,01 млн
-3,39 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-92,75 мың
-
Net interest expenses
-
-
-92,75 мың
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары